Research graph

References

References from Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study. Local targets link to admitted publications; unresolved targets remain external evidence.

No reference evidence is available for this admitted work.